Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 50
Summary
- Conditions
- Neuroblastoma
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 1218 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02245997
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Suzanne Wolden, MD Memorial Sloan Kettering Cancer Center
Get Well Soon